Avery L - Search Results

1

COVID-19 and Cancer Patients in the Second Year of the Pandemic: Investigating Treatment Impact, Information Sources, and COVID-19-Related Knowledge, Attitudes and Practices.

Ugas MA, Avery L, Wang Y, Berlin A, Giuliani ME, Krzyzanowska M, Papadakos TJ, Quartey NKL, Samoil D, Papadakos JK. Ugas MA, et al. Among authors: avery l. Curr Oncol. 2022 Nov 18;29(11):8917-8936. doi: 10.3390/curroncol29110701. Curr Oncol. 2022. PMID: 36421354 Free PMC article.

2

Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy.

Spiliopoulou P, Janse van Rensburg HJ, Avery L, Kulasingam V, Razak A, Bedard P, Hansen A, Chruscinski A, Wang B, Kulikova M, Chen R, Speers V, Nguyen A, Lee J, Coburn B, Spreafico A, Siu LL. Spiliopoulou P, et al. Among authors: avery l. Cell Death Dis. 2023 Jan 20;14(1):49. doi: 10.1038/s41419-022-05548-4. Cell Death Dis. 2023. PMID: 36670100 Free PMC article.

3

The role of [¹⁸F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer.

Basso Dias A, Mirshahvalad SA, Ortega C, Perlis N, Berlin A, van der Kwast T, Ghai S, Jhaveri K, Metser U, Haider M, Avery L, Veit-Haibach P. Basso Dias A, et al. Among authors: avery l. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2167-2176. doi: 10.1007/s00259-023-06136-0. Epub 2023 Feb 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 36809425

4

Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative Therapies.

Basso Dias A, Ghai S, Ortega C, Mirshahvalad SA, Perlis N, Berlin A, Avery L, Veit-Haibach P, van der Kwast T, Metser U. Basso Dias A, et al. Among authors: avery l. Clin Nucl Med. 2023 Oct 1;48(10):e462-e467. doi: 10.1097/RLU.0000000000004819. Clin Nucl Med. 2023. PMID: 37682613

5

The association of cancer-related fatigue on the social, vocational and healthcare-related dimensions of cancer survivorship.

Jones JM, Howell D, Longo C, Olson K, Bedard P, Amir E, Zheng S, Chow B, Avery L. Jones JM, et al. Among authors: avery l. J Cancer Surviv. 2023 Aug 30. doi: 10.1007/s11764-023-01451-9. Online ahead of print. J Cancer Surviv. 2023. PMID: 37644355

6

¹⁸F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study.

Metser U, Kulanthaivelu R, Chawla T, Johnson S, Avery L, Hussey D, Veit-Haibach P, Bernardini M, Hogen L. Metser U, et al. Among authors: avery l. Front Oncol. 2022 Oct 13;12:1025475. doi: 10.3389/fonc.2022.1025475. eCollection 2022. Front Oncol. 2022. PMID: 36313720 Free PMC article.

7

CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling.

Hinzpeter R, Kulanthaivelu R, Kohan A, Avery L, Pham NA, Ortega C, Metser U, Haider M, Veit-Haibach P. Hinzpeter R, et al. Among authors: avery l. Cancers (Basel). 2022 Dec 16;14(24):6224. doi: 10.3390/cancers14246224. Cancers (Basel). 2022. PMID: 36551709 Free PMC article.

8

¹H NMR metabolic profiling of synovial fluid from patients with anterior cruciate ligament tears and hemarthrosis.

Damyanovich AZ, Avery L, Staples JR, Marshall KW. Damyanovich AZ, et al. Among authors: avery l. Osteoarthritis Cartilage. 2023 Aug;31(8):1066-1077. doi: 10.1016/j.joca.2023.03.016. Epub 2023 May 3. Osteoarthritis Cartilage. 2023. PMID: 37146959

9

Contrast Enhanced CT Radiogenomics in a Retrospective NSCLC Cohort: Models, Attempted Validation of a Published Model and the Relevance of the Clinical Context.

Kohan A, Hinzpeter R, Kulanthaivelu R, Mirshahvalad SA, Avery L, Tsao M, Li Q, Ortega C, Metser U, Hope A, Veit-Haibach P. Kohan A, et al. Among authors: avery l. Acad Radiol. 2024 Feb 20:S1076-6332(24)00053-9. doi: 10.1016/j.acra.2024.01.031. Online ahead of print. Acad Radiol. 2024. PMID: 38383258 Free article.

10

Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancer.

Piedimonte S, Bernardini MQ, Ding A, Laframboise S, Ferguson SE, Bouchard-Fortier G, Avery L, May T, Hogen L. Piedimonte S, et al. Among authors: avery l. Int J Gynecol Cancer. 2023 Jul 3;33(7):1077-1082. doi: 10.1136/ijgc-2022-004202. Int J Gynecol Cancer. 2023. PMID: 37015756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

496 results

Search Page